The gut microbiota from lean and obese subjects contribute differently to the fermentation of arabinogalactan and inulin

PLoS ONE

Volumn 11, Issue 7, 2016, Pages

  Aguirre, Marisol ^a,b,c   De Souza, Carlota Bussolo ^c,d,e   Venema, Koen ^a,b,f  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c TNO   (Netherlands)

^d Ministério de Ciência Tecnologia e Inovação Salvador   (Brazil)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

^f Beneficial Microbes Consultancy ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOGALACTAN; BUTYRIC ACID; INULIN; PREBIOTIC AGENT; PROBIOTIC AGENT; PROPIONIC ACID; ACETIC ACID DERIVATIVE; BUTYRIC ACID DERIVATIVE; GALACTAN; PROPIONIC ACID DERIVATIVE; RNA 16S; VALERIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; ASCENDING COLON; BACTERIAL STRAIN; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY FIBER; FAECALIBACTERIUM PRAUSNITZII; FEMALE; FERMENTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; LACTOBACILLUS; LEAN BODY WEIGHT; MALE; MICROBIAL ACTIVITY; MICROFLORA; OBESITY; ENERGY METABOLISM; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY;

ACETATES; ADULT; BIFIDOBACTERIUM; BUTYRATES; DIETARY FIBER; ENERGY METABOLISM; FEMALE; FERMENTATION; GALACTANS; GASTROINTESTINAL MICROBIOME; HUMANS; INULIN; LACTOBACILLUS; MALE; OBESITY; PREBIOTICS; PROPIONATES; RNA, RIBOSOMAL, 16S; VALERATES;

EID: 84978529116     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0159236     Document Type: Article

References (77)

1. Yang J, Keshavarzian A, Rose DJ. Impact of dietary fiber fermentation from cereal grains on metabolite production by the fecal microbiota from normal weight and obese individuals. J Med Food. 2013; 16 (9):862-7. Epub 2013/09/21. doi: 10.1089/jmf.2012.0292 PMID: 24044495.
2. Elli M, Colombo O, Tagliabue A. A common core microbiota between obese individuals and their lean relatives? Evaluation of the predisposition to obesity on the basis of the fecal microflora profile. Med Hypotheses. 2010; 75(4):350-2. Epub 2010/04/13. S0306-9877(10)00135-0 [pii]doi: 10.1016/j.mehy. 2010.03.022 PMID: 20381974.
3. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012; 489(7415):220-30. Epub 2012/09/14. nature11550 [pii]doi: 10. 1038/nature11550 PMID: 22972295.
4. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001; 81(3):1031-64. Epub 2001/06/28. PMID: 11427691.
5. Russell WR, Gratz SW, Duncan SH, Holtrop G, Ince J, Scobbie L, et al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr. 2011; 93(5):1062-72. Epub 2011/03/11. ajcn.110.002188 [pii]doi: 10.3945/ajcn.110.002188 PMID: 21389180.
6. Freeland KR, Wolever TM. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha. Br J Nutr. 2010; 103(3):460-6. Epub 2009/10/13. S0007114509991863 [pii]doi: 10.1017/S0007114509991863 PMID: 19818198.
7. Tarini J, Wolever TM. The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab. 2010; 35(1):9-16. Epub 2010/02/05. h09-119 [pii]doi: 10.1139/H09-119 PMID: 20130660.
8. Anderson JW, Baird P, Davis RH, Ferreri S, Knudtson M, Koraym A, et al. Health benefits of dietary fiber. Nutrition Reviews. 2009; 67(4):188-205. doi: 10.1111/j.1753-4887.2009.00189.x PMID: 19335713
9. Liu S, Willett WC, Manson JE, Hu FB, Rosner B, Colditz G. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr. 2003; 78(5):920-7. Epub 2003/11/05. PMID: 14594777.
10. Royall D, Wolever TM, Jeejeebhoy KN. Clinical significance of colonic fermentation. The American journal of gastroenterology. 1990; 85(10):1307-12. PMID: 2220719.
11. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027-131. PMID: 17183312
12. Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010; 18(1):190-5. Epub 2009/06/06. oby2009167 [pii]doi: 10.1038/oby.2009.167 PMID: 19498350.
13. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009; 457(7228):480-4. Epub 2008/12/02. nature07540 [pii] doi: 10.1038/nature07540 PMID: 19043404.
14. Aguirre M, Jonkers DM, Troost FJ, Roeselers G, Venema K. In vitro characterization of the impact of different substrates on metabolite production, energy extraction and composition of gut microbiota from lean and obese subjects. PLoS One. 2014; 9(11):e113864. Epub 2014/11/27. doi: 10.1371/journal. pone.0113864 PONE-D-14-28411 [pii]. PMID: 25426858.
15. Payne AN, Chassard C, Zimmermann M, Muller P, Stinca S, Lacroix C. The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes. 2011; 1:e12. Epub 2011/01/01. nutd20118 [pii]doi: 10. 1038/nutd.2011.8 PMID: 23154580.
16. Sarbini SR, Kolida S, Gibson GR, Rastall RA. In vitro fermentation of commercial alpha-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. Br J Nutr. 2013; 109(11):1980-9. Epub 2012/11/03. S0007114512004205 [pii]doi: 10.1017/S0007114512004205 PMID: 23116939.
17. Sarbini SR, Kolida S, Deaville ER, Gibson GR, Rastall RA. Potential of novel dextran oligosaccharides as prebiotics for obesity management through in vitro experimentation. Br J Nutr. 2014; 112(8):1303-14. Epub 2014/09/10. S0007114514002177 [pii]doi: 10.1017/S0007114514002177 PMID: 25196744.
18. Bussolo de Souza C, Roeselers G, Troost F, Jonkers D, Koenen ME, Venema K. Prebiotic effects of cassava bagasse in TNO's in vitro model of the colon in lean versus obese microbiota. Journal of Functional Foods. 2014; 11:210-20. http://dx.doi.org/10.1016/j.jff.2014.09.019.
19. Condezo-Hoyos L, Mohanty IP, Noratto GD. Assessing non-digestible compounds in apple cultivars and their potential as modulators of obese faecal microbiota in vitro. Food Chemistry. 2014; 161:208-15. doi: 10.1016/j.foodchem.2014.03.122 PMID: 24837942
20. Robinson RR, Feirtag J, Slavin JL. Effects of dietary arabinogalactan on gastrointestinal and blood parameters in healthy human subjects. J Am Coll Nutr. 2001; 20(4):279-85. Epub 2001/08/17. PMID: 11506055.
21. Crociani F, Alessandrini A, Mucci MM, Biavati B. Degradation of complex carbohydrates by Bifidobacterium spp. Int J Food Microbiol. 1994; 24(1-2):199-210. Epub 1994/12/01. 0168-1605(94)90119-8 [pii]. PMID: 7703014.
22. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr. 2009; 101(4):541-50. Epub 2008/07/02. S0007114508019880 [pii]doi: 10.1017/S0007114508019880 PMID: 18590586.
23. Daguet D, Pinheiro I, Verhelst A, Possemiers S, Marzorati M. Arabinogalactan and fructooligosaccharides improve the gut barrier function in distinct areas of the colon in the Simulator of the Human Intestinal Microbial Ecosystem. Journal of Functional Foods. 2016; 20:369-79. http://dx.doi.org/10.1016/j.jff. 2015.11.005.
24. Kim LS, Waters RF, Burkholder PM. Immunological activity of larch arabinogalactan and Echinacea: a preliminary, randomized, double-blind, placebo-controlled trial. Altern Med Rev. 2002; 7(2):138-49. Epub 2002/05/07. PMID: 11991793.
25. Hauer J, Anderer FA. Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis. Cancer Immunol Immunother. 1993; 36(4):237-44. Epub 1993/01/01. PMID: 8439987.
26. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. Epub 2006/ 12/15. nature05485 [pii]doi: 10.1038/nature05485 PMID: 17167474.
27. Aguirre M, Ramiro-Garcia J, Koenen ME, Venema K. To pool or not to pool? Impact of the use of individual and pooled fecal samples for in vitro fermentation studies. J Microbiol Methods. 2014; 107C:1-7. Epub 2014/09/10. S0167-7012(14)00256-5 [pii]doi: 10.1016/j.mimet.2014.08.022 PMID: 25194233.
28. Aguirre M, Eck A, Koenen ME, Savelkoul PHM, Budding AE, Venema K. Evaluation of an optimal preparation of human standardized fecal inocula for in vitro fermentation studies. Journal of Microbiological Methods. 2015; 117:78-84. doi: 10.1016/j.mimet.2015.07.019 PMID: 26222994
29. van Nuenen MH, Diederick Meyer P, Venema K. The effect of various inulins and Clostridium difficile on the metabolic activity of the human colonic microbiota in vitro. Microbial Ecology in Health and Disease. 2003; 15(2-3):137-44.
30. de Graaf AA, Maathuis A, de Waard P, Deutz NE, Dijkema C, de Vos WM, et al. Profiling human gut bacterial metabolism and its kinetics using [U-13C]glucose and NMR. NMR Biomed. 2010; 23(1):2-12. Epub 2009/07/14. doi: 10.1002/nbm.1418 PMID: 19593762.
31. Maathuis A, Hoffman A, Evans A, Sanders L, Venema K. The effect of the undigested fraction of maize products on the activity and composition of the microbiota determined in a dynamic in vitro model of the human proximal large intestine. Journal of the American College of Nutrition. 2009; 28(6):657-66. PMID: 20516265
32. Van der Kamp JW, Jones J, Mccleary B, Topping DJ. Dietary Fibre: New Frontiers for Food and Health: Wageningen Academic Publishers; 2010.
33. Marino PL, Sutin KM. The ICU Book: Wolters Kluwer Health, Philadelphia, USA; 2012.
34. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, et al. Greengenes, a chimerachecked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006; 72(7):5069-72. Epub 2006/07/06. 72/7/5069 [pii]doi: 10.1128/AEM.03006-05 PMID: 16820507.
35. Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 2014; 42(Database issue):D633-42. Epub 2013/11/30. gkt1244 [pii]doi: 10.1093/nar/gkt1244 PMID: 24288368.
36. Lyon MR, Kacinik V. Is There a Place for Dietary Fiber Supplements in Weight Management? Curr Obes Rep. 2012; 1(2):59-67. Epub 2012/05/23. doi: 10.1007/s13679-012-0016-9 16 [pii]. PMID: 22611521.
37. Spill MK, Birch LL, Roe LS, Rolls BJ. Hiding vegetables to reduce energy density: an effective strategy to increase children's vegetable intake and reduce energy intake. Am J Clin Nutr. 2011; 94(3):735-41. Epub 2011/07/22. ajcn.111.015206 [pii]doi: 10.3945/ajcn.111.015206 PMID: 21775554.
38. Aguirre M, Venema K. Does the Gut Microbiota Contribute to Obesity? Going beyond the Gut Feeling. Microorganisms. 2015; 3(2):213-35.
39. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004; 101(44):15718-23. Epub 2004/10/ 27. 0407076101 [pii]doi: 10.1073/pnas.0407076101 PMID: 15505215.
40. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008; 3(4):213-23. Epub 2008/04/ 15. S1931-3128(08)00089-9 [pii]doi: 10.1016/j.chom.2008.02.015 PMID: 18407065.
41. Wanders AJ, Jonathan MC, van den Borne JJ, Mars M, Schols HA, Feskens EJ, et al. The effects of bulking, viscous and gel-forming dietary fibres on satiation. Br J Nutr. 2013; 109(7):1330-7. Epub 2012/ 08/02. S0007114512003145 [pii]doi: 10.1017/S0007114512003145 PMID: 22850326.
42. Cummings JH, Edmond LM, Magee EA. Dietary carbohydrates and health: do we still need the fibre concept? Clinical Nutrition Supplements. 2004; 1(2):5-17. http://dx.doi.org/10.1016/j.clnu.2004.09. 003.
43. Daniel M, Wisker E, Rave G, Feldheim W. Fermentation in human subjects of nonstarch polysaccharides in mixed diets, but not in a barley fiber concentrate, could be predicted by in vitro fermentation using human fecal inocula. J Nutr. 1997; 127(10):1981-8. Epub 1997/10/06. PMID: 9311954.
44. Bach Knudsen KE, Wisker E, Daniel M, Feldheim W, Eggum BO. Digestibility of energy, protein, fat and non-starch polysaccharides in mixed diets: comparative studies between man and the rat. Br J Nutr. 1994; 71(4):471-87. Epub 1994/04/01. PMID: 8011604.
45. Wisker E, Knudsen KEB, Daniel M, Eggum BrO, Feldheim W. Energy Values of Non-Starch Polysaccharides: Comparative Studies in Humans and Rats. The Journal of Nutrition. 1997; 127(1):108-16. PMID: 9040553
46. Cummings JH, Beatty ER, Kingman SM, Bingham SA, Englyst HN. Digestion and physiological properties of resistant starch in the human large bowel. Br J Nutr. 1996; 75(5):733-47. Epub 1996/05/01. S0007114596000773 [pii]. PMID: 8695600.
47. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta. 2010; 1801(11):1175-83. Epub 2010/08/10. S1388-1981(10)00167-8 [pii]doi: 10.1016/j.bbalip. 2010.07.007 PMID: 20691280.
48. Roelofsen H, Priebe MG, Vonk RJ. The interaction of short-chain fatty acids with adipose tissue: relevance for prevention of type 2 diabetes. Benef Microbes. 2010; 1(4):433-7. Epub 2011/08/13. 23506400165M7367 [pii]doi: 10.3920/BM2010.0028 PMID: 21831781.
49. Al-Lahham S, Roelofsen H, Rezaee F, Weening D, Hoek A, Vonk R, et al. Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects. Eur J Clin Invest. 2012; 42 (4):357-64. Epub 2011/09/15. doi: 10.1111/j.1365-2362.2011.02590.x PMID: 21913915.
50. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The Orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003; 278(13):11312-9. Epub 2002/12/24. doi: 10.1074/jbc.M211609200 M211609200 [pii]. PMID: 12496283.
51. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009; 461(7268):1282-6. Epub 2009/ 10/30. nature08530 [pii]doi: 10.1038/nature08530 PMID: 19865172.
52. MacFabe DF, Cain NE, Boon F, Ossenkopp KP, Cain DP. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder. Behav Brain Res. 2011; 217(1):47-54. Epub 2010/10/13. S0166-4328(10)00677-7 [pii]doi: 10.1016/j.bbr.2010.10.005 PMID: 20937326.
53. van de Wiele T, Boon N, Possemiers S, Jacobs H, Verstraete W. Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol. 2007; 102(2):452-60. Epub 2007/01/24. JAM3084 [pii]doi: 10.1111/j.1365-2672.2006.03084.x PMID: 17241351.
54. Grootaert C, Van den Abbeele P, Marzorati M, Broekaert WF, Courtin CM, Delcour JA, et al. Comparison of prebiotic effects of arabinoxylan oligosaccharides and inulin in a simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol. 2009; 69(2):231-42. Epub 2009/06/11. FEM712 [pii] doi: 10.1111/j.1574-6941.2009.00712.x PMID: 19508502.
55. Hughes SA, Shewry PR, Li L, Gibson GR, Sanz ML, Rastall RA. In vitro fermentation by human fecal microflora of wheat arabinoxylans. J Agric Food Chem. 2007; 55(11):4589-95. Epub 2007/05/10. doi: 10.1021/jf070293g PMID: 17488118.
56. Sakaguchi E, Sakoda C, Toramaru Y. Caecal fermentation and energy accumulation in the rat fed on indigestible oligosaccharides. Br J Nutr. 1998; 80(5):469-76. Epub 1999/01/30. S0007114598001548 [pii]. PMID: 9924269.
57. Juskiewicz J, Zdunczyk Z, Frejnagel S. Caecal parameters of rats fed diets supplemented with inulin in exchange for sucrose. Arch Anim Nutr. 2007; 61(3):201-10. Epub 2007/06/21. doi: 10.1080/ 17450390701297735 PMID: 17578262.
58. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008; 105(43):16731-6. Epub 2008/10/22. 0804812105 [pii]doi: 10.1073/pnas.0804812105 PMID: 18936492.
59. Velazquez OC, Lederer HM, Rombeau JL. Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implications. Adv Exp Med Biol. 1997; 427:123-34. Epub 1997/01/01. PMID: 9361838.
60. Willing B, Halfvarson J, Dicksved J, Rosenquist M, Jarnerot G, Engstrand L, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis. 2009; 15(5):653-60. Epub 2008/11/22. doi: 10.1002/ibd.20783 PMID: 19023901.
61. Basson MD, Turowski GA, Rashid Z, Hong F, Madri JA. Regulation of human colonic cell line proliferation and phenotype by sodium butyrate. Dig Dis Sci. 1996; 41(10):1989-93. Epub 1996/10/01. PMID: 8888712.
62. Vince AJ, McNeil NI, Wager JD, Wrong OM. The effect of lactulose, pectin, arabinogalactan and cellulose on the production of organic acids and metabolism of ammonia by intestinal bacteria in a faecal incubation system. Br J Nutr. 1990; 63(1):17-26. Epub 1990/01/01. S0007114590000071 [pii]. PMID: 2317475.
63. De Preter V, Falony G, Windey K, Hamer HM, De Vuyst L, Verbeke K. The prebiotic, oligofructoseenriched inulin modulates the faecal metabolite profile: an in vitro analysis. Mol Nutr Food Res. 2010; 54(12):1791-801. Epub 2010/06/23. doi: 10.1002/mnfr.201000136 PMID: 20568238.
64. De Preter V, Vanhoutte T, Huys G, Swings J, De Vuyst L, Rutgeerts P, et al. Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol. 2007; 292(1):G358-68. Epub 2006/09/23. 00052.2006 [pii]doi: 10.1152/ajpgi.00052.2006 PMID: 16990449.
65. DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc. 2008; 83(4):460-9. Epub 2008/04/03. S0025-6196(11)60702-7 [pii]doi: 10.4065/83.4.460 PMID: 18380992.
66. Tilg H. Obesity, metabolic syndrome, and microbiota: multiple interactions. J Clin Gastroenterol. 2010; 44 Suppl 1:S16-8. Epub 2010/06/11. doi: 10.1097/MCG.0b013e3181dd8b64 PMID: 20535027.
67. de Graaf AA, Venema K. Gaining insight into microbial physiology in the large intestine: a special role for stable isotopes. Adv Microb Physiol. 2008; 53:73-168. Epub 2007/08/21. S0065-2911(07)53002-X [pii]doi: 10.1016/S0065-2911(07)53002-X PMID: 17707144.
68. Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr. 2011; 94(1):58-65. Epub 2011/05/06. ajcn.110.010132 [pii]doi: 10.3945/ajcn.110.010132 PMID: 21543530.
69. Santacruz A, Marcos A, Warnberg J, Marti A, Martin-Matillas M, Campoy C, et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring). 2009; 17(10):1906-15. Epub 2009/04/25. oby2009112 [pii]doi: 10.1038/oby.2009.112 PMID: 19390523.
70. Macfarlane GT, Macfarlane S, Gibson GR. Co-culture of Bifidobacterium adolescentis and Bacteroides thetaiotaomicron in arabinogalactan-limited chemostats: effects of dilution rate and pH. Anaerobe. 1995; 1(5):275-81. Epub 1995/10/01. S1075-9964(85)71027-X [pii]doi: 10.1006/anae.1995.1027 PMID: 16887536.
71. Zocco MA, Ainora ME, Gasbarrini G, Gasbarrini A. Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. Dig Liver Dis. 2007; 39(8):707-12. Epub 2007/07/03. S1590-8658(07) 00138-7 [pii]doi: 10.1016/j.dld.2007.04.003 PMID: 17602905.
72. Venema K, Maathuis AJ. A PCR-based method for identification of bifidobacteria from the human alimentary tract at the species level. FEMS Microbiol Lett. 2003; 224(1):143-9. Epub 2003/07/12. S0378109703004361 [pii]. PMID: 12855182.
73. Roberfroid MB. Prebiotics: preferential substrates for specific germs? Am J Clin Nutr. 2001; 73(2 Suppl):406S-9S. Epub 2001/02/07. PMID: 11157349.
74. Korpela K, Flint HJ, Johnstone AM, Lappi J, Poutanen K, Dewulf E, et al. Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS One. 2014; 9(6): e90702. Epub 2014/03/08. doi: 10.1371/journal.pone.0090702 PONE-D-13-40143 [pii]. PMID: 24603757.
75. Davis LM, Martinez I, Walter J, Hutkins R. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol. 2010; 144(2):285-92. Epub 2010/11/10. S0168-1605(10)00559-3 [pii]doi: 10.1016/j.ijfoodmicro.2010.10.007 PMID: 21059476.
76. Kolida S, Meyer D, Gibson GR. A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Eur J Clin Nutr. 2007; 61(10):1189-95. Epub 2007/02/03. 1602636 [pii]doi: 10.1038/sj.ejcn.1602636 PMID: 17268410.
77. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007; 50(11):2374-83. Epub 2007/09/08. doi: 10.1007/s00125-007-0791-0 PMID: 17823788.